本页面由Tiger Trade Technology Pte. Ltd.提供服务

Evaxion Biotech A/S

3.87
+0.29008.10%
盘后3.870.00000.00%17:47 EDT
成交量:4.38万
成交额:16.04万
市值:3,213.14万
市盈率:-3.87
高:3.92
开:3.60
低:3.51
收:3.58
52周最高:12.15
52周最低:1.20
股本:830.27万
流通股本:553.19万
量比:1.29
换手率:0.79%
股息:- -
股息率:- -
每股收益(TTM):-1.0000
每股收益(LYR):-1.0000
净资产收益率:-100.18%
总资产收益率:-28.23%
市净率:1.89
市盈率(LYR):-3.87

数据加载中...

2026/03/05

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/11/21

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2025/04/01

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/03/21

SEC问询函

Form CORRESP - Correspondence
2025/01/29

SEC问询函

Form CORRESP - Correspondence
2025/01/28

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/12/18

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/12/05

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/11/18

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/20

SEC问询函

Form CORRESP - Correspondence
2024/08/20

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/07/22

SEC问询函

Form CORRESP - Correspondence
2024/07/22

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/06

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/03/26

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/01/31

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/01/31

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/01/30

SEC问询函

Form CORRESP - Correspondence